Cell-Free DNA Isolation And Extraction Market Competitive Landscape 2024-2033 – Major Players and Strategies

 

Overview and Scope
The cell-free DNA isolation and extraction market consists revenues earned by entities by providing services such as sample collection and stabilization, isolation protocols, and quality control and quantification. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell-free DNA isolation and extraction market consists of sales of automated extraction systems, high-speed centrifugation machines, magnetic bead separators, polymerase chain reaction (PCR) machines, and microfluidic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Sizing and Forecast
The cell-free DNA isolation and extraction market size has grown strongly in recent years. It will grow from $1.81 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%.  The growth in the historic period can be attributed to a rise in prevalence of cancer, rise in the field of microbial sequencing, significant investments by healthcare companies, rise in investments in genomics and biotechnology, rise in investment in research and development.

The cell-free DNA isolation and extraction market size is expected to see strong growth in the next few years. It will grow to $2.49 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.  The growth in the forecast period can be attributed to the growing adoption of cell-free deoxyribonucleic acid (DNA) isolation and extraction kits and tubes, rising investments in genomics and biotechnology, advancements in molecular diagnostics, growing demand for personalized medicine, increasing prevalence of chronic and infectious diseases. Major trends in the forecast period include the development of new products, strategic partnerships and collaborations, mergers and acquisitions, technological advancement, and new product launches.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-free-dna-isolation-and-extraction-global-market-report

Segmentation & Regional Insights
The cell-free DNA isolation and extraction market covered in this report is segmented –
1) By Product Type: Kits, Reagents, Instruments
2) By Technology: Column-Based Isolation And Extraction, Magnetic Beads, Silica Membranes
3) By Application: Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Biotech And Pharma Companies

North America was the largest region in the cell-free DNA isolation and extraction market in 2023. The regions covered in the cell-free DNA isolation and extraction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16371&type=smp

Major Driver Impacting Market Growth
The rising prevalence of cancer is expected to propel the growth of the cell-free DNA isolation and extraction market going forward. Cancer is a complex group of diseases characterized by the uncontrolled growth and spread of abnormal cells, often forming tumors, with the potential to invade other parts of the body, impair normal bodily functions, and, if left untreated, result in severe illness or death. Cancer cases are increasing due to the obesity epidemic, inherited genetic abnormalities, hepatitis B and C viruses, Epstein-Barr virus (EBV), and human papillomavirus (HPV). Cell-free DNA (cfDNA) extraction and isolation techniques enable comprehensive genomic analysis of cancer, offering valuable insights into tumor biology, treatment response, and disease progression. These techniques potentially revolutionize cancer management by facilitating early detection, personalized treatment approaches, and improved patient outcomes. For instance, in May 2024, according to the American Society of Clinical Oncology, a US-based professional organization, approximately 20 million new cases of cancer were diagnosed in 2022, which is estimated to reach 35 million by 2050, resulting in an estimated 9.7 million deaths attributed to the disease. Therefore, the rising prevalence of cancer is driving the growth of the cell-free DNA isolation and extraction market.

Role Of Personalized Medicine In Expanding The Cell-Free DNA Isolation And Extraction Market

The growing demand for personalized medicine is expected to propel the growth of the cell-free DNA isolation and extraction market going forward. Personalized medicine is a medical approach that customizes healthcare decisions and treatments for individual patients based on their genetic makeup, environmental factors, and lifestyle. The growing demand for personalized medicines is driven by higher rates of cancer and the increasing incidence of chronic diseases among the population. Cell-free DNA isolation and extraction in personalized medicine offer a non-invasive and comprehensive approach to diagnosing, monitoring, and treating diseases, particularly cancer, based on an individual's unique genetic makeup. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, 12 new customized medications were approved in 2022, accounting for around 34% of all newly approved treatments, a significant increase over prior years. Therefore, the growing demand for personalized medicine is driving the growth of the cell-free DNA isolation and extraction market.

Key Industry Players
Major companies operating in the cell-free DNA isolation and extraction market are F. Hoffmann-La Roche AG, Merck KGaA, Novartis AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Natera Inc., Promega Corporation, STRATEC Biomedical AG, STRECK Inc., Omega Bio-tek Inc., SeraCare Life Sciences Inc., Yourgene Health plc, System Biosciences LLC, PreAnalytiX GmbH, Bioo Scientific Corporation, BioCAT GmbH, Norgen Biotek Corp., Epigentek Group Inc., NVIGEN Inc.

The cell-free dna isolation and extraction market report table of contents includes:
1. Executive Summary
2. Cell-Free DNA Isolation And Extraction Market Characteristics
3. Cell-Free DNA Isolation And Extraction Market Trends And Strategies
4. Cell-Free DNA Isolation And Extraction Market - Macro Economic Scenario
5. Global Cell-Free DNA Isolation And Extraction Market Size and Growth
…………….
32. Global Cell-Free DNA Isolation And Extraction Market Competitive Benchmarking
33. Global Cell-Free DNA Isolation And Extraction Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cell-Free DNA Isolation And Extraction Market
35. Cell-Free DNA Isolation And Extraction Market Future Outlook and Potential Analysis
36. Appendix